Search

Author/Creator Glasmacher, Axel

1. 283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs). (9th November 2020)

Authors:
Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 376 A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors. (9th November 2020)

Authors:
Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (10th December 2020)

Authors:
Lythgoe, Mark; Stebbing, Justin; Pickford, Emily; Glasmacher, Axel; Adriani, Marsilio; Fyvie, Gayle; Frampton, Adam; Stevenson, Alex; Krell, Jonathan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (9th November 2020)

Authors:
Lythgoe, Mark; Stebbing, Justin; Pickford, Emily; Glasmacher, Axel; Adriani, Marsilio; Fyvie, Gayle; Frampton, Adam; Stevenson, Alex; Krell, Jonathan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A854
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review. (10th March 2020)

Authors:
Mayer, Karin; Hahn‐Ast, Corinna; Schwab, Katjana; Schmidt‐Wolf, Ingo G. H.; Brossart, Peter; Glasmacher, Axel; von Lilienfeld‐Toal, Marie
Journal:
European journal of haematology
Issue:
Volume 104:Number 6(2020)
Page Start:
538
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗